USE OF SODA-LIME BOROSILICATE GLASS BEADS IN A COSMETIC PREPARATION TO REDUCE SANDY ADHESION TO THE SKIN

Description

[0001] The present invention relates to the use of glass beads made of sodium hydroxide borosilicate in cosmetic preparations.

[0002] The desire to look beautiful and attractive is rooted in human nature. Even though the ideal of beauty has changed over time, the pursuit of a flawless appearance has always been a human goal. The condition and appearance of the skin plays a significant role in achieving a beautiful and attractive appearance.

[0003] For the skin to fully perform its biological functions, it requires regular cleansing and care. Cleansing the skin serves to remove dirt, sweat, and dead skin cells, which provide an ideal breeding ground for pathogens and parasites of all kinds. Skin cleansing is generally achieved using surface-active preparations (soaps, surfactants, and less frequently, alcoholic preparations) that are available as foaming gels or solids (soap bars) and are rinsed off with water after application to the skin.

[0004] Skin care products, usually creams, ointments, or lotions, primarily serve to moisturize and replenish the skin's natural oils. They often contain active ingredients intended to regenerate the skin and, for example, prevent and reduce premature aging (such as the formation of fine lines and wrinkles).

[0005] However, the large number of commercially available skin care products, including sunscreens, should not obscure the fact that these state-of-the-art preparations have a number of disadvantages.

[0006] Cosmetic skincare products, even those based on an ethanolic solution, typically contain oil components and other more or less sticky ingredients that cause dust-like, fine-grained particles to adhere more strongly to the skin. This problem is particularly bothersome with sunscreens used by consumers at the beach. The issue of so-called sand adhesion to sunscreens has been repeatedly described in the literature. However, the problem also occurs with other cosmetic products and in other everyday situations, for example, with day or night creams in combination with house dust or pollen.

[0007] EP 1 506 772 A2 uses glass microspheres (glass beads) in sunscreens to reduce their stickiness. Sodium hydroxide borosilicate spheres are given as examples.

[0008] It was therefore the object of the present invention to reduce the particle adhesion to the skin caused by the cosmetic preparation and in particular the sand adhesion to the skin caused by the cosmetics (especially sunscreens).

[0009] One possible solution to the problem according to the prior art is to incorporate so-called powder raw materials made of room-temperature solid plastic particles into the preparations. These room-temperature solid plastic particles consist of polyethylene, polypropylene, polymethyl methacrylate, or nylon. This is also the definition of these substances according to the invention. A disadvantage of this prior art is that the use of these substances is increasingly viewed as undesirable in connection with the so-called "microplastics" debate, i.e., the discussion about the use of plastic particles in cosmetics and their fate in the environment after cosmetic application. Whether and, if so, to what extent this debate is justified can remain open within the scope of this disclosure. However, it is a fact that consumers are showing increasing interest in cosmetic products that no longer contain these ingredients.

[0010] It was therefore the object of the present invention to reduce the particle adhesion to the skin caused by the cosmetic preparation and in particular the sand adhesion to the skin caused by the cosmetics (especially sunscreens), without using room temperature solid plastic particles, i.e. polyethylene, polypropylene, polymethyl methacrylate or nylon.

[0011] These tasks are surprisingly solved by a use according to claim 1.

[0012] According to the invention, it is preferred if the preparation is free of plastic particles that are solid at room temperature.

[0013] While the prior art includes glass beads for cosmetic preparations, for example made of alkali-lime glass (e.g., from GP Cosmetics) or magnesium silicate (e.g., Covabead Crystal from Sensient Cosmetic Technologies), these have the disadvantage of causing discoloration in emulsions, the most common type of cosmetic preparation. Stability problems also exist with silica-based encapsulated UV filters (e.g., Eusolex UV-Pearls from Merck). However, the objective of the present invention was to develop stable (especially color-stable) preparations, particularly emulsions (and specifically oil-in-water emulsions).

[0014] According to the invention, it is advantageous if the glass beads according to the invention have a particle diameter of 5 to 120 µm.

[0015] The particle size (particle diameter) of the glass beads according to the invention can be determined, for example, by sieving, in accordance with the usual standards. It is of course known to those skilled in the art that the particle size (grain size) is always subject to a certain size distribution. The specified size therefore means that no glass beads larger than those with a particle diameter of 120 µm are used, and it is not critical if small quantities of smaller particles are present in the preparation as impurities (for example, resulting from broken glass).

[0016] It is advantageous according to the invention if the glass beads according to the invention are hollow.

[0017] Advantageous embodiments of the present invention are characterized in that the density of the glass beads is 0.1 to 1.0 g / cubic centimeter. A density of 0.13 to 0.63 is preferred according to the invention.

[0018] Furthermore, according to the invention, it is advantageous if the glass beads have an oil absorption of 0.2 to 0.6 grams of oil per cubic centimeter of glass beads, measured according to ASTM D281-95. An oil absorption of 0.3 to 0.5 grams of oil per cubic centimeter of glass beads, measured according to ASTM D281-95, is preferred according to the invention.

[0019] It is advantageous in the sense of the present invention if the glass beads have a pH value of 9 to 10, measured according to ASTM D3100-1982.

[0020] According to the invention, it is advantageous if the glass beads have a softening temperature of 550 to 650 °C. The softening is determined after 2 hours of storage at the corresponding temperature. A softening temperature of 590 to 610 °C is preferred according to the invention, ideally being 600 °C.

[0021] According to the invention, it is advantageous if the preparation contains the glass beads in an amount of 0.1 to 10% by weight, based on the total weight of the preparation. A content of 1 to 6% by weight, based on the total weight of the preparation, is preferred according to the invention.

[0022] Advantageous embodiments of the present invention are characterized in that the oil phase of the preparation comprises one or more oil components selected from the group consisting of the following compounds: diisopropyl adipate, caprylic / capric triglyceride (INCI: Caprylic / Capric Triglycerides), isopropyl palmitate, dimethicone, cyclomethicone, octyldodecanol, ethylhexyl cocoate, myristyl myristate, hydrogenated coco-glycerides (INCI: Hydrogenated Coco-Glycerides), dicaprylyl carbonate, C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate), di-n-butyl adipate, butylene glycol dicaprylate / dicaprate (INCI: Butylene Glycol Dicaprylate / Dicaprate), C12-15 alkyl benzoate (INCI: C12-15 Alkyl Benzoate), and 2-phenylethyl benzoate (INCI: Phenethyl Benzoates), Di C12-13 Alkyl Tatrate (INCI Di-C12-13 Alkyl Tatrate), Butylene Glycol Cocoate (INCI: Butylene Glycol Cocoate), Dicaprylyl Ether, Isodecyl Neopentanoate, Tridecyl Trimelliate, Isopropyl Stearate, C12.13 alkyl lactate, 2-propylheptyloctanoate, isopropyl lauryl sarcosinate.

[0023] The oil components preferred according to the invention are diisopropyl adipate, caprylic / capric triglyceride (INCI Caprylic / Capric Triglycerides), octyldodecanol, ethylhexyl cocoate, myristyl myristate, hydrogenated coco-glycerides (INCI Hydrogenated Coco-Glycerides), di-n-butyl adipate, butylene glycol dicaprylate / dicaprate (INCI Butylene Glycol Dicaprylate / Dicaprate), C12-15 alkyl benzoate (INCI C12-15 Alkyl Benzoate), and 2-phenylethyl benzoate (INCI Phenethyl Benzoate).

[0024] It is advantageous according to the invention if the total quantity of these advantageous oil components according to the invention is from 1 to 20% by weight of the total weight of the preparation, wherein the preferred quantity range is from 2 to 15% by weight of the total weight of the preparation.

[0025] It is advantageous according to the invention if the preparation according to the invention contains one or more UV filters selected from the group consisting of the following compounds: phenylene-1,4-bis-(2-benzimidazole)-3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxa-nyl]propyl]phenol; 3-benzylidene camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(Dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 2-Hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-Dihydroxy-4-methoxybenzophenone; 2-(4'-Diethylamino-2'-hydroxybenzoyl)-benzoic acid hexyl ester, 4-(tert.-Butyl)-4'-methoxydiben-zoylmethan; Homomenthylsalicylat; 2-Ethylhexyl-2-hydroxybenzoat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-meth-oxysiloxan / Dimethylsiloxan - Copolymer; Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazin (INCI: Ethylhexyl Triazone); 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin; 4-Dicyanomethylen-2,6-dimethyl-1,4-dihydropyridin-N-(ethyloxysulfatestersalze), Titandioxid; Zinkoxid.

[0026] Furthermore, the use of 4-(tert-Butyl)-4'-methoxydibenzoylmethane, ; 2-(4'-Diethylamino-2'-hydroxybenzoyl)-benzoic acid hexyl ester (INCI: Diethylamino hydroxybenzoyl hexyl benzoate), 2-Phenylbenzimidazole-5-sulfonic acid salts, ethylhexyl salicylate; Dioctylbutylamidotriazone (INCI: Diethylhexyl-Butamidotriazone), 4,4',4"-(1,3,5-Triazine-2,4,6-triyltriimino)-tris-benzoic acid-tris(2-ethylhexyl ester) (also: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone) and 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine are particularly preferred according to the invention, wherein these UV filters can be used individually or as a mixture.

[0027] It is advantageous within the meaning of the present invention if the preparation contains one or more alcohols selected from the group consisting of ethanol, glycerin, ethylhexylglycerin, phenoxyethanol, polyglyceryl-2 caprate, propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, and 1,2-decanediol. These emulsifiers can be used in a total concentration of 0.2 to 80% by weight, based on the total weight of the preparation.

[0028] Advantageous embodiments of the present invention are characterized in that the preparation contains one or more compounds selected from the group consisting of alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, polydocanol, tocopheryl acetate, dihydroxyacetone, glyceryl glycose, (2-hydroxyethyl)urea, vitamin E or vitamin E acetate, hyaluronic acid and / or their sodium salts, menthol, glycyrrhetinic acid and / or licochalcone A.

[0029] Last but not least, it is advantageous according to the invention if the preparation contains one or more polymers selected from the group of compounds xantham gum, tapioca starch, hydroxyethylcellulose, carbomer, acrylate / C10-30 alkyl acrylate, vinylpyrrolidone / hexadecene copolymer.

[0030] Furthermore, the cosmetic preparation can be composed like a cosmetic product commonly used in such cases and contain the corresponding, known ingredients. Vergleichsversuch

[0031] The following formulas were prepared and the sand adhesion was determined using the following method. inci sweat 249 _sweat_260 _sweat_261 Glasperlen größter Durchmesser ca. 150 µm (z.B. 3M Glass Bubbles K15) 0 5 0 Glasperlen größter Durchmesser ca. 30 µm (z.B. 3M GLASS BUBBLES IM30K) 0 0 5 Tocopheryl Acetate 0,11 0,11 0,11 Menthol 0,05 0,05 0,05 C12-15 Alkyl Benzoate 5 5 5 Diisopropyl Adipate 3 3 3 Butylene Glycol Dicaprylate / Dicaprate 4 4 4 Polyglyceryl-3 Methylglucose Distearate 0,2 0,2 0,2 Silica Dimethyl Silylate 1 1 1 Tapioca Starch + Aqua 4 4 4 Parfum 0,4 0,4 0,4 Glycerin + Aqua 1 1 1 Aqua + Sodium Hydroxide 0,623 0,623 0,623 Phenoxyethanol 0,5 0,5 0,5 Hydroxyethylcellulose 0,1 0,1 0,1 Carbomer 0,125 0,125 0,125 Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0,2 0,2 0,2 Xanthan Gum 0,2 0,2 0,2 Aqua ad 100 ad 100 ad 100 Alcohol Denat. + Aqua 10 10 10 Aqua + Trisodium EDTA 1 1 1 Ethylhexyl Salicylate 5 5 5 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 4 4 4 Ethylhexyl Triazone 3 3 3 Butyl Methoxydibenzoylmethane 4,75 4,75 4,75 Phenylbenzimidazole Sulfonic Acid 1 1 1 In-vitro Sand adhesion

[0032] 50 mg of the test emulsion was applied to PMMA Schönberg plates (5.0 x 5.0 cm) and evenly distributed across the plate using a finger cot. The applied sample formulation was then dried for 15 minutes at room temperature. The weight of the dried plates was then determined using an analytical balance. Subsequently, the plates were coated with an excess of fine sea sand (1.07711.1000 Pure Sea Sand, Merck KGaA). Any loosely adhering sand was removed with reproducible, uniform force by sliding the plates once on a designated sliding device (see below).

[0033] The amount of sand remaining on the slab was determined by weighing. The sand adhesion can be calculated using the following equation: The slide is a triangular structure with a slide width of 5 cm. The slide is a right-angled triangle with a slide width of 5 cm. The adjacent side of the right-angled triangle (the base of the slide) has a length of 13.5 cm, and the opposite side (the drop height) has a length of 49 cm. The hypotenuse, on which the sliding action takes place, and the base form an angle of 275°.

[0034] The tests were repeated 10 times for each recipe and the corresponding average value was calculated.

[0035] Individual data on sand adhesion: Muster w Platte in q w Platte+Sand in q w Sand absolut in q Mittelwert Standardabweichung SW EAT:249 a-15 7.292 7.35 0.058 SW EAT:249 b-15 7.297 7.423 0.126 SWAET:249 c-15 7.299 7.429 0.13 SWAET:249 d-15 7.27 7.376 0.106 SWEAT:249 e-15 7.311 7.395 0.084 SW EAT:249 f-15 7.279 7.385 0.106 SW EAT:249 g-15 7.169 7.287 0.118 SWEAT:249 h-15 7.301 7.35 0.049 SWEAT:249 i-15 7.305 7.434 0.129 SW EAT:249 j-15 7.29 7.396 0.106 0.101 0.029 SWEAT:260 a-15 7.292 7.294 0.002 SWEAT:260 b-15 7.311 7.314 0.003 SWAET:260 c-15 7.216 7.218 0.002 SWAET:260 d-15 7.152 7.154 0.002 SWEAT:260 e-15 7.106 7.11 0.004 SWEAT:260 f-15 7.285 7.287 0.002 SWEAT:260 g-15 7.172 7.179 0.007 SW EAT:260 h-15 7.166 7.17 0.004 SWEAT:260 i-15 7.199 7.207 0.008 SWEAT:260 j-15 7.323 7.329 0.006 0.004 0.002 SWEAT:261 a-15 7.264 7.301 0.037 SWEAT:261 b-15 7.249 7.252 0.003 SWAET:261 c-15 7.313 7.322 0.009 0 SWAET:261 d-15 7.323 7.327 0.004 SWEAT:261 e-15 7.298 7.318 0.02 SWEAT:261 f-15 7.307 7.317 0.01 SWEAT:261 g-15 7.325 7.332 0.007 SWEAT:261 h-15 7.291 7.299 0.008 SWEAT:261 i-15 7.291 7.295 0.004 SWEAT:261 j-15 7.325 7.331 0.006 0.011 0.010 Muster anhaftender Sand in mg / cm 2< (15 Minuten) Standardabweichung SWEAT:249 N-free 4,0 1,16 SWEAT:260 N-free + 5 % 3M Glass Bubbles K15 0,2 0,08 SWEAT:261 N-free + 5 % 3M Glass Bubbles IM30K 0,4 0,4 Beispiele

[0036] The following examples are intended to illustrate the present invention without limiting it. Unless otherwise stated, all quantities, proportions, and percentages are based on the weight and total quantity or total weight of the preparations. Beispiele 1 2 3 4 5 6 7 8 9 10 INCI m[%] m[%] m[%] m[%] m[%] m[%] m[%] m[%] m[%] m[%] Glasperlen größter Durchmesser ca. 30 µm (z.B. 3M GLASS BUBBLES IM30K) 2,5 5 2 6 3 Glasperlen größter Durchmesser ca. 150 µm (z.B. 3M Glass Bubbles K15) 2,5 5 2 6 3 VP / Hexadecene Copolymer 0,5 1 0,5 1 0,5 Tocopherylacetate 0,06 0,1 0,01 0,15 0,06 0,5 0,1 0,06 0,15 0,1 Panthenol 1 1,4 0,5 0,5 1 1 0,5 Ethylhexylglycerin 0,3 0,5 0,25 0,3 0,25 1,2-Hexandiole 0,4 1 1 Methylpropanediole 0,2 0,2 C12-15 Alkylbenzoate 4,5 6 3 6 7 7,5 Caprylic / Capric Triglycerides 4 2 3 Isopropyl Palmitate 4 3 3 Dimethicone 2 1 0,5 Octyldodecanol 2 2 Ethylhexyl Cocoate 1 2 3 Myristyl Myristate 2 1 1,5 1 Cetearyl Alcohol 1 1,5 1 Hydrogenated Coco-Glycerides 5 2 1 Butylene Glycol Dicaprylate / Dicaprate 1 3 1,5 2 Dicaprylyl Carbonate 1 3 3 1,5 C18-38 Alkyl Hydroxystearoyl Stearate 0,5 Polyglyceryl-3 Methylglucose Distearate 0,15 0,15 Glyceryl Stearate Citrate 2 3 2 2 Glyceryl Stearate 1 1 Sodium Stearoyl Glutamate 0,5 Glyceryl Stearate SE 1 1 Sodium Cetearal Sulfate 0,15 0,15 0,15 Silica dimethyl Silylate 0,5 0,5 0,3 1 0,5 1 Tapioca starch 3 3 Parfum 0,4 0,3 0,2 0,4 0,4 0,5 0,3 0,2 Glycerin 6 8 5 1 1 5 8 6 5 1 Citric Acid 0,07 0,09 0,01 0,008 Sodium Citrate 0,16 0,15 0,16 0,17 Sodium Hydroxide 0,05 0,08 0,07 0,08 0,05 0,03 0,07 0,06 0,03 Phenoxyethanol 0,3 0,5 0,3 0,4 0,5 0,2 0,5 0,3 0,4 Methylparaben 0,2 0,3 0,2 0,2 0,3 0,4 0,2 0,3 Ethylparaben 0,2 0,3 0,2 0,3 0,2 0,3 Stearyl Alcohol 0,8 0,8 1 0,8 1,5 Acrylates / C10-30Alkyl Acrylates Crosspolymer 0,1 0,15 0,05 0,2 0,1 0,05 0,15 0,2 Carbomer 0,15 Hydroxyethylcellulose 0,1 Xanthan Gum 0,3 0,2 0,5 0,4 0,3 0,4 0,2 0,3 0,3 Cetyl Alcohol 0,5 1 2 Alcohol Denat 4 6 4 8 10 4 6 6 8 10 Trisodium EDTA 1 0,5 1 1 1 0,5 0,5 1 1 1 Homosalate 9 9 9 9,5 9 9 9 9 9 Octocrylene 9 9 9,5 8 8 Ethylhexyl Salicylate 4,5 4,75 4,75 4,75 4,75 4,75 4,75 4,75 4,75 Butyl Methoxydibebzoylmethane 4,5 4,5 4,75 4,75 4,75 4,5 4,5 4,75 4,75 Titanium dioxide 3 6 1 3,5 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 3 4 4 3,5 4 4 3,5 3 4 Ethylhexyl Triazone 3 3 3 3 3 Diethylamino Hydroxybenzoyl Hexvlbenzoate 8 Polysilicone-15 1 Phenylbenzimidazole Sulfonic Acid 1 1 1 1 1,5 1,5 1 Aqua ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100

Claims

1. Use of soda-lime-borosilicate glass beads in a cosmetic preparation comprising at least one oil phase, wherein the preparation is in the form of an O / W emulsion, which has been emulsified with one or more emulsifiers selected from the group of compounds comprising glyceryl stearate citrate, glyceryl stearate (self-emulsifying), polyglyceryl-3 methylglycose distearate, sodium stearoyl glutamate, sodium cetearyl sulfate, potassium cetyl phosphate, cetearyl sulfosuccinate, polyglyceryl-10 stearate, polyglyceryl-10 laurate, polyglyceryl-10 caprate, wherein the preparation is free of 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, 2-hydroxy-4-methoxybenzophenone, 2-ethyl hexyl 4-methoxycinnamate, isoamyl 4-methoxycinnamate and 3-(4-methylbenzylidene)camphor, for reducing the adhesion of sand to the skin.

2. Use according to Claim 1, characterized in that the preparation is free of plastic particles solid at room temperature.

3. Use according to either of the preceding claims, characterized in that the glass beads have a particle diameter of 5 to 120 µm.

4. Use according to any of the preceding claims, characterized in that the glass beads are hollow.

5. Use according to any of the preceding claims, characterized in that the density of the glass beads is 0.1 to 1.0 g / cubic centimetre.

6. Use according to any of the preceding claims, characterized in that the glass beads have an oil absorption of 0.2 to 0.6 grams of oil per cubic centimetre of glass beads, measured in accordance with ASTM D281-95.

7. Use according to any of the preceding claims, characterized in that the glass beads have a pH of 9 to 10, measured in accordance with ASTM D3100-1982.

8. Use according to any of the preceding claims, characterized in that the glass beads have a softening temperature of 550 to 650°C.

9. Use according to any of the preceding claims, characterized in that the preparation comprises the glass beads in an amount of 0.1 to 10% by weight, based on the total weight of the preparation.

10. Use according to any of the preceding claims, characterized in that the oil phase of the preparation comprises one or more oil components selected from the group of compounds comprising diisopropyl adipate, caprylic / capric triglyceride (INCI Caprylic / Capric Triglycerides), isopropyl palmitate, dimethicone, cyclomethicone, octyldodecanol, ethylhexyl cocoate, myristyl myristate, hydrogenated coco-glycerides (INCI Hydrogenated Coco-Glycerides), dicaprylyl carbonate, C18-38 alkyl hydroxystearoryl stearate (INCI C18-38 Alkyl Hydroxystearoyl Stearate), di-n-butyl adipate, butylene glycol dicaprylate / dicaprate (INCI Butylene Glycol Dicaprylate / Dicaprate), C12-15 alkyl benzoate (INCI C12-15 Alkyl Benzoate), 2-phenylethyl benzoate (INCI Phenethyl Benzoate), di C12-13 alkyl tartrate (INCI Di-C12-13 Alkyl Tartrate), butylene glycol cocoate (INCI: Butylene Glycol Cocoate), dicaprylyl ether, isodecyl neopentanoate, tridecyl trimellitate, isopropyl stearate, C12.13 alkyl lactate, 2-propylheptyl octanoate, isopropyl lauryl sarcosinate.

11. Use according to any of the preceding claims, characterized in that the preparation comprises one or more UV filters selected from the group of compounds comprising phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and salts thereof; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]phenol; 3-benzylidenecamphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 2-ethylhexyl 4-(dimethylamino)benzoate; amyl 4-(dimethylamino)benzoate; di(2-ethylhexyl) 4-methoxybenzalmalonate; 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; hexyl 2-(4'-diethylamino-2'-hydroxybenzoyl)benzoate; 4-(tert-butyl)-4'-methoxydibenzoylmethane; homomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3-(4-(2,2-bis ethoxycarbonylvinyl)phenoxy)propenyl)methoxysiloxane / dimethylsiloxane - copolymer; dioctylbutylamidotriazone (INCI: Diethylhexyl Butamidotriazone); 2,4-bis[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine with (CAS No. 288254-16-0); tris(2-ethylhexyl) 4,4',4"-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoate (also: 2,4,6-tris[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone); 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine; 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine N-(ethyloxysulfate ester salts), titanium dioxide; zinc oxide.

12. Use according to any of the preceding claims, characterized in that the preparation comprises one or more alcohols selected from the group of compounds comprising ethanol, glycerol, ethylhexylglycerin, phenoxyethanol, polyglyceryl-2 caprate, propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol.

13. Use according to any of the preceding claims, characterized in that the preparation comprises one or more compounds selected from the group of compounds comprising alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, polidocanol, tocopheryl acetate, dihydroxyacetone, glycerylglucose, (2-hydroxyethyl)urea, vitamin E and vitamin E acetate, hyaluronic acid and / or sodium salts thereof, menthol, gylcyrrhetic acid and / or licochalcone A.

14. Use according to any of the preceding claims, characterized in that the preparation comprises one or more polymers selected from the group of compounds comprising xanthan gum, tapioca starch, hydroxyethylcellulose, carbomer, acrylate / C10-30 alkyl acrylate, vinylpyrrolidone / hexadecene copolymer.